Shaanxi Meibang Pharmaceutical Hits Day High with 9.99% Surge

Shaanxi Meibang Pharmaceutical Group Co., Ltd. has experienced a significant surge in its stock price, gaining 9.99% on August 10, 2026. The stock reached an intraday high of CNY 19.60, marking a notable performance compared to the broader market, as the China Shanghai Composite index only increased by 0.67% on the same day. Over the past week, Shaanxi Meibang has shown an impressive 8.17% increase, outpacing the China Shanghai Composite's 4.12% rise. In the last month, the stock has risen by 12.84%, while the composite index has declined by 0.74%. However, the company's one-year performance remains in the negative territory, with a decrease of 8.33%, contrasting sharply with the composite's 9.12% gain. Despite the recent uptick, the company faces challenges, including a high debt-to-equity ratio and a return on equity of 5.29%. The market capitalization stands at CNY 662 million, categorizing it as a small-cap stock within the Chemicals & Petrochemicals industry. Investors will be closely monitoring how these dynamics evolve in the coming days.